Bristol-Myers Squibb
NYS:BMY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
About
Pharmaceuticals: MajorFounded 1933
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
Headquarters
Executives
Name | Title | Gender |
Sandra Leung | Executive Vice President & General Counsel | Female |
John E. Elicker, MBA | Senior VP-Public Affairs & Investor Relations | Male |
Thomas James Lynch, Jr., MD | Chief Scientific Officer & Executive VP | Male |
Charles A. Bancroft, MBA, CPA | CFO, EVP & Head-Global Business Operations | Male |
Paul von Autenried | Chief Information Officer & Senior Vice President | Male |
Giovanni Caforio, MD | Chairman & Chief Executive Officer | Male |
Ann Powell Judge | Chief Human Resources Officer & Senior VP | Female |
Mindful Investing Summary
Bristol-Myers Squibb - Competitors and Related Companies
How Bristol-Myers Squibb stacks up to its peers in thePharmaceuticals: Major industry or with competing business segments.
Bristol-Myers Squibb
NYS:BMY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Amgen
NAS:AMGN
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
Celgene
NAS:CELG
Biotechnology
—
MEGA cap
(—)
—
since start of 2022
—
Eli Lilly
NYS:LLY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Johnson & Johnson
NYS:JNJ
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Sanofi
PAR:SAN-FR
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—